Abacavir Sulfate

CHEMBL4303288 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

670.7 g/mol

LogP

—

Phase

4

The sulfate salt form of abacavir, an antiretroviral medicine used to treat HIV infection with the same mechanism and precautions as abacavir itself. It is taken orally, usually once or twice daily as part of a combination HIV therapy regimen. Patients should be screened for the HLA-B*5701 gene variant before starting treatment to avoid a potentially life-threatening hypersensitivity reaction.

Masse moléculaire

670,7000 g/mol

TPSA

287,00 Å²

Aires thérapeutiques

Infectious Disease Generalized Anxiety Disorder Psoriasis Systemic Lupus Erythematosus Stroke Major Depressive Disorder Breast Cancer Gout Malaria HIV/AIDS Hepatitis C Tuberculosis Cardiovascular Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.Nc1nc(NC2CC2)c2ncn([C@H]3C=C[C@@H](CO)C3)c2n1.O=S(=O)(O)O

InChI

InChI=1S/2C14H18N6O.H2O4S/c2*15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21;1-5(2,3)4/h2*1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19);(H2,1,2,3,4)/t2*8-,10+;/m11./s1

Molecular Formula

C28H38N12O6S

HBD / HBA

8 / 16

Liaisons Rotatives

8

Atomes Lourds

47

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

The sulfate salt form of abacavir, an antiretroviral medicine used to treat HIV infection with the same mechanism and precautions as abacavir itself. It is taken orally, usually once or twice daily as part of a combination HIV therapy regimen. Patients should be screened for the HLA-B*5701 gene variant before starting treatment to avoid a potentially life-threatening hypersensitivity reaction.

Yes, Abacavir Sulfate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4303288. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 441384. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Abacavir Sulfate sur PillFYI

Structure

Données Clés

Formule: C28H38N12O6S
Synonymes: 5

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.